Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/1284| Recent discovery and development of inhibitors targeting coronaviruses | |
| Pillaiyar, T Meenakshisundaram, S Manickam, M | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| Human coronaviruses (CoVs) are enveloped viruses with a positive-sense single-stranded RNA genome. Currently, six human CoVs have been reported including human coronavirus 229E (HCoV-229E), OC43 (HCoV-OC43), NL63 (HCoV-NL63), HKU1 (HCoV-HKU1), severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and MiddleEast respiratory syndrome (MERS) coronavirus (MERS-CoV). They cause moderate to severe respiratory and intestinal infections in humans. In this review, we focus on recent advances in the research and development of small-molecule anti-human coronavirus therapies targeting different stages of the CoV life cycle. | |
| Drug Discovery Today | |
| 2020 | |
| Preimpreso | |
| https://coronavirus.1science.com/item/f56a46dfc4ab73c0962ff95cb2037f311b0ce9da | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 107371.pdf | 2.49 MB | Adobe PDF | Visualizar/Abrir |